Orlistat

Xenical, Alli, Beacita

Bibliografia - Quali fonti bibliografiche per Orlistat?

1. Asberg A., Drugs, 2003, 63 (4), 367.


2. Barbaro D. et al., Endocr. Pract., 2002, 8 (2), 124.


3. Beaver J et al., 1st International Congress on Abdominal Obesity, 2010, 28-30 gennaio, Honk Kong, Cina.


4. Bigham S. et al., Epilepsia, 2006, 47 (12), 2207.


5. Borgstrom B., Biochim. Biophys. Acta, 1988, 962, 308.


6. Bryson A. et al., Br. J. Clin. Pharmacol., 2009, 67 (3), 309.


7. Chaikomin R. et al., Br. J. Nutr., 2006, 96 (5), 883.


8. Chanoine J.P. et al., JAMA, 2005, 293 (23), 2873.


9. Czerwienska B. et al., Pol. Arch. Med. Wewn., 2004, 112 (6), 1415.


10. Didangelos T.P. et al., Curr. Med. Res. Opin., 2004, 20 (9), 1393.


11. Du J., Wang Z., Med. Hypotheses, 2009, 73 (5), 662.


12. Evans S. et al., Am. J. Kidney Dis., 2003, 41 (2), 493.


13. Filippatos T.D. et al., Drug Saf., 2008, 31 (1), 53.


14. Hadvary et al., Biochem. J., 1988, 256, 357.


15. Hartmann D. et al., Eur. J. Clin. Pharmacol., 1996, 50 (5), 421.


16. Heck A.M. et al., Ann. Pharmacother., 2002, 36 (6), 1003.


17. Hilger E. et al., J. Clin. Psychopharmacol., 2002, 22 (1), 68.


18. Holecki M. et al., Int. J. Obes. (Lond.), 2006, 30 (6), 1017.


19. Karamadoukis L. et al., Clin. Nephrol., 2009, 71 (4), 430.


20. Kelley D.E. et al., Diabetes Care, 2004, 27 (1), 33.


21. Kopelman P. et al., Obesity (Silver Spring), 2010, 18 (1), 108.


22. MacWalter R.S. et al., Ann. Pharmacother., 2003, 37 (4), 510.


23. Melia A.T. et al., J. Clin. Pharmacol., 1995, 35 (8), 840.


24. Melia A.T. et al., J. Clin. Pharmacol., 1996, 36 (4), 352.


25. Melia A.T. et al., J. Clin. Pharmacol., 1996a, 36 (7), 654.


26. Nägele H. et al., Eur. J. Clin. Pharmacol., 1999, 55 (9), 667.


27. O’Connor M.B., Ir. J. Med. Sci., 2010, 179 (2), 315.


28. Padwal R. et al., Int. J. Obes. Relat. Metab. Disord., 2003, 27 (12), 1437.


29. Persson M., Vitols S., BMJ, 2000, 321, 87.


30. Ringman J.M., Mozaffar T., Neuromuscul. Disord., 2008, 18 (5), 410.


31. Sarica K. et al., Obesity (Silver Spring), 2008, 16 (7), 1579.


32. Sharma A.M., Golay A., J. Hypertens., 2002, 20, 1873.


33. Shi Y.F. et al., Diabet. Med., 2005, 22 (12), 1737.


34. Sjöström L. et al., Lancet, 1998, 352 (9123), 167.


35. Sundl I. et al., Lipids, 2006, 41 (2), 113.


36. Toplak H. et al., Diabetes Obes. Metab., 2005, 7 (6), 699.


37. Torgerson J.S. et al., Diabetes Care, 2004, 27 (1), 155.


38. Valsecia M.E. et al., Ann. Pharmacother., 2001, 35, 1496.


39. Weber C. et al., Eur. J. Clin. Pharmacol., 1996, 51 (1), 87.


40. Weibel et al., J. Antibiot. Tokyo, 1987, 40, 1081.


41. Wirth A., Diabetes Obes. Metab., 2005, 7 (1), 21.


42. Zhi J. et al., Clin. Pharmacol. Ther., 1994, 56, 82.


43. Zhi J. et al., J. Clin. Pharmacol., 1995, 35, 1103.


44. Zhi J. et al., J. Clin. Pharmacol., 1995a, 35 (5), 521.


45. Zhi J. et al., J. Clin. Pharmacol., 1996, 36 (7), 659.


46. Zhi J. et al., J. Clin. Pharmacol., 1996a, 36 (11), 1006.


47. Zhi J. et al., J. Clin. Pharmacol., 2002, 42 (9), 1011-9.


48. Zhi J. et al., J. Clin. Pharmacol., 2003, 43 (4), 428.


49. Zhi J. et al., J. Am. Coll. Nutr., 2003a, 22 (5), 357.